HIV Epidemiology

• US
• Worldwide

HIV Screening

• Guidelines
• Opt-Out vs. Opt-In screening
  • Evaluating exposure risk

HIV Testing

• Interpretation of tests
• Types of tests
  • Rapid Test
  • 4^th Generation Test

Acute HIV

• Clinical manifestations
• Diagnosis
• Linkage to Care

Management of HIV Infection

• Initial management
  • History and physical
  • Ordering laboratory tests
    • CD4/VL
    • HIV Genotype
    • Safety labs (CBC, chem panel)
    • Screening for STIs and viral hepatitis
    • Screening for substance abuse
    • Screening for mental health problems
  • Immunizations
  • HIV disclosure
• HIV treatment
  • ARV management (according to DHHS Guidelines)
    • Initiation
    • Switching
    • Simplification
    • Managing common symptoms and side effects of ARV
    • Drug-drug interactions
    • Adherence
    • IRIS
    • Virologic failure
    • Immunologic failure
  • Resistance testing
    • Genotype/Phenotype testing
    • Archived resistance testing
• Immunizations
  • Influenza
  • Pneumococcal
  • Hepatitis A
  • Hepatitis B
  • Other
• Practical clinical management
  • Diarrhea
  • Headache
  • Fatigue
  • Fever
  • Lymphadenopathy
  • Substance Abuse
    • Methamphetamine
    • Tobacco
    • Other
  • Nutrition
  • Exercise
• Psychosocial
  • Disclosure of HIV status/Confidentiality
  • Returning to work
  • Stigma
  • Aging
  • Death and dying
    • Palliative care/End of Life care

Disease States associated with HIV Infection/AIDS

• Opportunistic Infections and AIDS Defining Conditions
  • Bacterial
    • Recurrent bacterial infections
    • Recurrent pneumonia
    • Salmonella septicemia
  • Mycobacterial
    • Mycobacterium Tuberculosis (TB)
    • Mycobacterium Avium Complex (MAC) or Atypical mycobacterial infection
  • Viral
    • Cytomegalovirus (CMV)
    • Varicella Zoster Virus (VZV)
    • Herpes Simplex Virus (HSV)
    • Progressive Multifocal Leukoencephalopathy (JC Virus)
  • Fungal
    • Candidiasis
    • Cryptococcus
    • Coccidiodomycosis
    • Histoplasmosis
  • Parasitic
    • Pneumocystis jirovecii pneumonia (PJP)
    • Toxoplasmosis
    • Cryptosporidium
    • Isospora
  • Malignancies
    • Cancer Screening
    • Kaposi’s Sarcoma
    • Lymphoma (Burkitt’s, Immunoblastic, Primary CNS)
    • Anal dysplasia/cancer
    • Cervical dysplasia/cancer
  • Other
    • HIV encephalopathy
    • AIDS wasting
    • Lymphoid Interstitial Pneumonia
  • Prophylaxis
    • Starting Prophylaxis
      • Primary Prophylaxis
      • Secondary Prophylaxis
    • Stopping Prophylaxis
• Other Comorbidities
  • Cardiovascular
    • Myocardial Infarction
    • Cardiovascular Disease
  • Pulmonary
    • COPD
  • Renal
    • HIV-Associated Nephropathy
  • Hepatic
    • Hepatitis A
    • Hepatitis B
    • Hepatitis C
  • Gastrointestinal
    • Chronic Diarrhea
  • Metabolic/Endocrine
    • Dyslipidemia
    • Diabetes
    • Lipodystrophy
    • Wasting
    • Osteopenia/Osteoporosis
    • Hypogonadism
  • Neurologic
    • HAND
    • Dementia
  • Psychiatric
    • Depression
    • Anxiety
    • Psychosis
  • Hematologic
    • Anemia
    • Neutropenia
    • Thrombocytopenia
  • Dermatologic
    • Seborrheic Dermatitis
    • Eosinophilic Folliculitis
    • Psoriasis
  • STDs
    • Syphilis
    • Gonorrhea/Chlamydia
  • Oral/Dental Health

Special Populations

• MSM
• Heterosexuals
• Women
  • Pregnancy
• Infants and Children
• Transgender
• African-American
• Latino
• Injection drug use (IDU)
• Aging
• Corrections
• Chronic pain

HIV Prevention

• Sexual history taking
• Condom/barrier protection
• Perinatal Transmission
• Pre-Exposure Prophylaxis (PrEP)
  • Guidelines
• Post-Exposure Prophylaxis
  • Occupational (PEP)
  • Non-occupational (nPEP)

Conference Updates

• CROI
• International Workshop on Co-Morbidities and Adverse Drug Reactions in HIV
• European AIDS Conference
• International AIDS Conference
• IDSA
• ID Week

Hot Topics